KATHERINE WATSON: Open Payments
NPI 1487429726 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$136 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $220 · 2025 $136
Food & beverage: $136
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 2 | $51 |
| Organon LLC | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $15 |
| CooperSurgical, Inc. | 1 | $15 |
Products named: MYFEMBREE, NEXPLANON, Lynkuet, Paragard T 380A.
Industry payments across MD — which companies pay providers there.
